US 7314731
Method for selecting therapeutic agents for cancer
granted A61PA61P17/02A61P31/00
Quick answer
US patent 7314731 (Method for selecting therapeutic agents for cancer) held by Precision Therapeutics, Inc. expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision Therapeutics, Inc.
- Grant date
- Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P17/02, A61P31/00, A61P35/00, A61P37/02